LFM
AZN icon

LGT Fund Management’s AstraZeneca AZN Stock Holding History

LGT Fund Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.1M Buy
139,758
+35,767
+34% +$6.73M 1.09% 17
2026
Q1 		$20.2M Buy
103,991
+84,012
+421% +$16.2M 0.88% 20
2025
Q4 		$3.7M Hold
19,979
– – 0.29% 88
2025
Q3 		$3.37M Hold
19,979
– – 0.27% 91
2025
Q2 		$2.79M Buy
19,979
+5,043
+34% +$707K 0.24% 103
2025
Q1 		$2.2M Sell
14,936
-7,494
-33% -$1.08M 0.2% 112
2024
Q4 		$2.94M Buy
22,430
+8,850
+65% +$1.24M 0.26% 82
2024
Q3 		$2.16M Sell
13,580
-8,875
-40% -$1.43M 0.22% 97
2024
Q2 		$3.5M Hold
22,455
– – 0.44% 62
2024
Q1 		$3.04M Buy
22,455
+1,300
+6% +$172K 1.27% 30
2023
Q4 		$2.85M Hold
21,155
– – 1.22% 30
2023
Q3 		$2.82M Hold
21,155
– – 1.37% 22
2023
Q2 		$3.03M Sell
21,155
-4,525
-18% -$666K 1.39% 21
2023
Q1 		$3.56M Sell
25,680
-13,700
-35% -$1.84M 1.52% 18
2022
Q4 		$5.34M Hold
39,380
– – 2.31% 10
2022
Q3 		$4.32M Hold
39,380
– – 2.03% 12
2022
Q2 		$5.2M Buy
39,380
+7,500
+24% +$984K 0.76% 32
2022
Q1 		$4.26M Buy
31,880
+30,000
+1,596% +$3.6M 0.57% 44
2021
Q4 		$219K Buy
+1,880
New +$221K 0.06% 167

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LGT Fund Management's AZN Position: Q2 2026 in Review

LGT Fund Management increased its AstraZeneca (AZN) stake by 34% in Q2 2026, buying an estimated $6.73M and bringing the position to 139,758 shares worth $26.1M. The position accounts for 1.09% of the portfolio, ranked #17.

LGT Fund Management first reported a position in AZN in Q4 2021 and has held it in 19 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • LGT Fund Management held 139,758 shares of AstraZeneca worth $26.1M as of Q2 2026.
  • LGT Fund Management bought 35,767 AstraZeneca shares in Q2 2026, an estimated $6.73M.
  • AstraZeneca made up 1.09% of LGT Fund Management's portfolio in Q2 2026, its #17 holding.
  • LGT Fund Management first reported a position in AstraZeneca in Q4 2021 and has held it in 19 quarters since.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.